Tenax Therapeutics Provides Update on TNX-102, TNX-103 and TNX-201 Clinical Programs
Go back to Tenax Therapeutics Provides Update on TNX-102, TNX-103 and TNX-201 Clinical Programs| (NASDAQ: TENX) | Delayed: 2.13 -0.06 (2.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.19 | 52 Week High | $3.40 | |||
| Open | $2.16 | 52 Week Low | $1.34 | |||
| Day High | $2.29 | P/E | N/A | |||
| Day Low | $2.12 | EPS | $0.00 | |||
| Volume | 2,801,305 | |||||

